Bhavi Pandya1, Azfar Sheikh2, Jonathan Spagnola2, Soad Bekheit3, James Lafferty3, Marcin Kowalski3. 1. Department of Internal Medicine, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY, 10305, USA. dr.bhavipandya@gmail.com. 2. Department of Internal Medicine, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY, 10305, USA. 3. Department of Cardiology, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY, 10305, USA.
Abstract
BACKGROUND: The newer second-generation cryoballoons (CB-2 or Arc-Adv-CB) have been shown to achieve significantly lower temperature and faster pulmonary vein isolation (PVI) time in comparison with first-generation cryoballoons (CB-1 or Arc-CB). To test the premise that second-generation cryoballoons can improve clinical outcomes in comparison to first-generation cryoballoons in terms of safety and efficacy, we pooled data for systemic review and meta-analyses from all available literature comparing their clinical performance. METHODS: The Cochrane Library, PubMed, Google Scholar, and studies presented at various meetings were searched for any published literature comparing safety and efficacy of the second-generation cryoballoons (Arctic Front Advance cryoballoons) with first-generation cryoballoons (Arctic Front Cryoballoons). A total of ten published studies, with 2310 patients, were included in this meta-analysis with 957 patients in second-generation cryoballoon group and 1237 patients in first-generation cryoballoon group. RESULTS: The pooled analysis showed significant superiority of second-generation cryoballoons in terms of less procedure time, less fluoroscopic time, and fewer incidences of arrhythmia recurrences compared to first-generation cryoballoons at the cost of higher incidence of persistent and transient phrenic nerve palsy. The differences in the rate of pericardial effusion and incidence of access site complications were not statistically significant. CONCLUSIONS: Second-generation cryoballoons are associated with a shorter procedure time and fluoroscopy time, along with lower arrhythmia recurrence rates, reflecting higher procedure efficacy when compared to first-generation cryoballoons. However, they are also associated with a higher incidence of transient and persistent phrenic nerve palsies with a non-significant difference in rates of access site complications and pericardial effusion.
BACKGROUND: The newer second-generation cryoballoons (CB-2 or Arc-Adv-CB) have been shown to achieve significantly lower temperature and faster pulmonary vein isolation (PVI) time in comparison with first-generation cryoballoons (CB-1 or Arc-CB). To test the premise that second-generation cryoballoons can improve clinical outcomes in comparison to first-generation cryoballoons in terms of safety and efficacy, we pooled data for systemic review and meta-analyses from all available literature comparing their clinical performance. METHODS: The Cochrane Library, PubMed, Google Scholar, and studies presented at various meetings were searched for any published literature comparing safety and efficacy of the second-generation cryoballoons (Arctic Front Advance cryoballoons) with first-generation cryoballoons (Arctic Front Cryoballoons). A total of ten published studies, with 2310 patients, were included in this meta-analysis with 957 patients in second-generation cryoballoon group and 1237 patients in first-generation cryoballoon group. RESULTS: The pooled analysis showed significant superiority of second-generation cryoballoons in terms of less procedure time, less fluoroscopic time, and fewer incidences of arrhythmia recurrences compared to first-generation cryoballoons at the cost of higher incidence of persistent and transient phrenic nerve palsy. The differences in the rate of pericardial effusion and incidence of access site complications were not statistically significant. CONCLUSIONS: Second-generation cryoballoons are associated with a shorter procedure time and fluoroscopy time, along with lower arrhythmia recurrence rates, reflecting higher procedure efficacy when compared to first-generation cryoballoons. However, they are also associated with a higher incidence of transient and persistent phrenic nerve palsies with a non-significant difference in rates of access site complications and pericardial effusion.
Authors: Wendy S Tzou; Francis E Marchlinski; Erica S Zado; David Lin; Sanjay Dixit; David J Callans; Joshua M Cooper; Rupa Bala; Fermin Garcia; Mathew D Hutchinson; Michael P Riley; Ralph Verdino; Edward P Gerstenfeld Journal: Circ Arrhythm Electrophysiol Date: 2010-03-24
Authors: Alexander Fürnkranz; Stefano Bordignon; Boris Schmidt; Laura Perrotta; Daniela Dugo; Manuel De Lazzari; Britta Schulte-Hahn; Bernd Nowak; Julian K R Chun Journal: Europace Date: 2015-01-06 Impact factor: 5.214
Authors: Kudret Aytemir; Kadri Murat Gurses; Muhammed Ulvi Yalcin; Duygu Kocyigit; Muhammet Dural; Banu Evranos; Hikmet Yorgun; Ahmet Hakan Ates; Mehmet Levent Sahiner; Ergun Baris Kaya; Mehmet Ali Oto Journal: Europace Date: 2014-11-05 Impact factor: 5.214
Authors: Jonathan P Piccini; Renato D Lopes; Melissa H Kong; Vic Hasselblad; Kevin Jackson; Sana M Al-Khatib Journal: Circ Arrhythm Electrophysiol Date: 2009-12
Authors: Alexander Fürnkranz; Stefano Bordignon; Boris Schmidt; Melanie Gunawardene; Britta Schulte-Hahn; Verena Urban; Frank Bode; Bernd Nowak; Julian K R Chun Journal: J Cardiovasc Electrophysiol Date: 2013-02-11
Authors: Thomas Neumann; Jürgen Vogt; Burghard Schumacher; Anja Dorszewski; Malte Kuniss; Hans Neuser; Klaus Kurzidim; Alexander Berkowitsch; Marcus Koller; Johannes Heintze; Ursula Scholz; Ulrike Wetzel; Michael A E Schneider; Dieter Horstkotte; Christian W Hamm; Heinz-Friedrich Pitschner Journal: J Am Coll Cardiol Date: 2008-07-22 Impact factor: 24.094
Authors: Cara East; Teresa Phan; Giovanni Filardo; Jay Franklin; Alan Donsky; Kevin R Wheelan; Robert C Kowal Journal: Proc (Bayl Univ Med Cent) Date: 2017-01
Authors: B Koektuerk; H Yorgun; A Koch; C H Turan; K Keskin; A Dahmen; C Hoppe; E Gorr; P M Bansmann; R G Turan; M Horlitz; A Yang Journal: Herz Date: 2016-06-22 Impact factor: 1.443
Authors: Thomas J Buist; Ahmet Adiyaman; Jaap Jan J Smit; Anand R Ramdat Misier; Arif Elvan Journal: Clin Res Cardiol Date: 2018-02-06 Impact factor: 5.460
Authors: Wilber Su; G Joseph Orme; Robert Hoyt; James Baker; Steven Compton; Christopher Fellows; John Harding; J Thomas Svinarich; Marcin Kowalski; Bryan Piedad; David Kenigsberg; John Seger; Zeshan K Ahmad; Paul Wang Journal: J Interv Card Electrophysiol Date: 2018-02-24 Impact factor: 1.900